FactSet Research Systems Inc. looks undervalued with strong Q3 growth, FY26 guidance intact, and AI-driven margin upside.
Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year over year to ...
The partnership brings FactSet’s trusted financial intelligence directly into agentic advisor workflows, helping advisors deliver personalized ...
Hosted on MSN
MDAI: DeepView FDA clearance fires up our valuation
Spectral AI, Inc. (NASDAQ: MDAI) announced De Novo clearance for its DeepView Burn diagnostic in a May 26 th press release. As a result, we increase our probability of success for DeepView burn from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results